Jul 28, 2021 by Jason HawthorneWhy CoStar Group Stock Is Falling TodayManagement is lowering guidance but keeping long-term targets in place.
Jul 28, 2021 by Jason HawthorneWill Teladoc Be a Trillion-Dollar Stock by 2040?Even if the company can grow to the moon, it might leave shareholders behind.
Jul 28, 2021 by Jason Hawthorne2 Best Buys of the Nasdaq Right NowThe overall market might be expensive, but these stocks aren't.
Jul 27, 2021 by Jason Hawthorne3 Reasons Caribou Biosciences Could Be the Best Gene-Editing Stock for Your PortfolioThe company has a pedigree and a novel approach that could put it at the top of the CRISPR heap.
Jul 25, 2021 by Jason Hawthorne3 Reasons Clover Health's Future May Be Even Brighter than Its PastDespite a lot of noise around the stock, the company has a few paths to grow much larger than it is now.
Jul 24, 2021 by Jason Hawthorne3 Reasons Clover Health Stock Is ControversialThis unlikely meme stock gives bulls and bears a lot to chew on.
Jul 22, 2021 by Jason Hawthorne3 Healthcare Stocks to Buy and Hold for the Next 10 YearsDon't overthink it -- buy companies with excellent financials and a long runway for growth.
Jul 21, 2021 by Jason Hawthorne2 Stocks I'm Never SellingIt's the only way to take advantage of what makes each of these businesses special.
Jul 20, 2021 by Jason HawthorneWhy Coinbase, Dogecoin, Ethereum, and Bitcoin Are Falling TodayInterest in the cryptocurrency space continues to erode as prices lose elevation.
Jul 19, 2021 by Jason HawthorneWhy Shares of Vaxart Jumped 31.2% in the First Half of 2021The first half has been a cycle of hope and disappointment for shareholders.
Jul 19, 2021 by Jason HawthorneWhy Shares of Ocugen Climbed TodayThe delta variant is lifting the tide of companies associated with COVID testing and prevention.
Jul 19, 2021 by Jason HawthorneWhy Shares of Fulgent Genetics Rose 77% in the First Half of 2021The stock has traded with the ebbs and flows of COVID cases, but its testing has consistently delivered for its impressive list of customers.
Jul 19, 2021 by Jason HawthorneWhy Shares of GoodRx Fell 10.7% in the First Half of 2021Slowing user growth and the long shadow of a competitor dampened enthusiasm for the stock.
Jul 16, 2021 by Jason HawthorneWhy CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This WeekAfter rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.
Jul 16, 2021 by Jason HawthorneBuy This Stock Before It Becomes a Dividend AristocratOnce it gets on the list, people are more likely to realize how cheap it is.
Jul 15, 2021 by Jason HawthorneThe First Stock I'm Going to Buy in the Next Stock Market CorrectionThe company has several tailwinds, but it's being priced like a different business since the pandemic began.
Jul 14, 2021 by Jason HawthorneWhy Shares of Axsome Therapeutics Are Falling TodayThe FDA took back a beneficial designation but management isn't changing its plans.
Jul 14, 2021 by Jason Hawthorne5 Stocks to Own for the Surge in Coronavirus VariantsDespite easing restrictions, COVID is going to be around a lot longer than many think.
Jul 13, 2021 by Jason Hawthorne3 Reasons I Just Bought Boston Beer StockThe company has returned to growth thanks to its popular drinks and America's desire to imbibe.
Jul 11, 2021 by Jason HawthorneDon't Wait for the Market Crash to Buy This Value StockBuying this great business at a fair price will generate better returns than waiting for a pullback that might never come.
